Marijuana Stock Investors: 4 Forces Dragging Cannabis Market Profitability in 2020

Here are four strong market structural forces that make the Canadian marijuana industry potentially unprofitable for most players.

Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

The Canadian marijuana market continues to evolve in 2020. National recreational sales are growing at a rapid pace across the country with August cannabis retail sales reaching the $244.9 million mark, up 94% year over year.

However, most investors in marijuana stocks are sitting on steep capital losses, as the major cannabis market players, including Canopy Growth (TSX:WEED)(NYSE:CGC), Aphria (TSX:APHA)(NASDAQ:APHA), and Aurora Cannabis (TSX:ACB)(NYSE:ACB), struggle to impress a disappointed investor community.

Most of the challenges facing the nascent cannabis industry have to do with its evolving market structure. They include fast-growing rivalry among incumbents, a rapid influx of new entrants, strong bargaining power of a few buyers, and the threat of close substitutes from a resilient illicit market. I will briefly touch on these four items.

An influx of new market entrants

The threat of new competitive entrants significantly impacts industry profitability. There’s an ongoing influx of new players into the Canadian marijuana market.

Health Canada is flooding the marijuana industry with new market entrants right now. The number of applicants that have received licences rose to 525 by October 27, up from 269 at the end of 2019. Nearly half (48.8%) of total cannabis business licence holders since 2013 were granted their licences within the first 10 months of this year. That’s quite a number.

Health Canada Cannabis license numbers, 2013-October 27, 2020.
Health Canada increases the pace of new cannabis licence issuance. Data from Health Canada (accessed Oct,27,2020).

A sudden influx of new entrants into the game exerts pressure on incumbent players. A significant number of new licensees target micro-cultivation and the medical cannabis market. This was a key segment where healthy gross margins remained after price wars eroded margins in the adult-use dry flower market.

Medical marijuana margins will most likely shrink in the coming months, as new players promote new products to gain market share. The vapes and edibles segment could see price wars too, as new players disrupt the game.

Strong bargaining power of cannabis buyers

Due to regulatory design, the Canadian cannabis market is heavily controlled by a few large institutional buyers who control pricing. The provinces hold the clout in this industry. They are at times the sole wholesale buyer of the product.

Although Alberta, Ontario, and the Yukon somehow opened up the retail space to free-market players, (with strict licensing requirements), online stores remain the preserve of provincial bodies in most instances.

A few large buyers aren’t the best recipe for success in any market set-up. They can bargain competitively and chew up manufacturing margins from licensed producers.

Most noteworthy, I don’t like it when over 80 sellers try bargaining with just one buyer at any one time. Such is the case in Ontario. Worse still, the province is on a campaign to outmaneuver the illicit marijuana market in a price war. The Ontario Cannabis Store managed to undercut the illegal market price points for the first time ever recently.

The point is, the government has the pricing power, and producers are price takers. They have little influence on margins besides lowering production costs. Yet they still need to pay licensing costs and incur significant regulatory compliance expenses. Profitability may remain a pipedream for some.

Cheap substitutes from illicit market dealers

As mentioned above, for the first time ever in Ontario, consumers could buy legal cannabis products at a lower price than the illegal market in October 2020. Law enforcement has been vigilant in fighting the illicit pot market after seizing over $143 million worth of inventory recently.

However, the real threat to industry margins still remains. Illegal players have lower operating expenses, and they will remain a threat to industry pricing power and margins for decades. Licensed pot companies will remain mindful of this threat and will keep prices low enough to remain competitive.

Growing industry rivalry

Price competition is a deadly game in any industry. Yet cannabis players enjoy undercutting each other right now. Some will say HEXO started it. Yes, it needed volume growth to survive. Aurora followed, it had the same target. Almost everyone has a value brand now, and average prices keep falling. Margins are being thrown out the window.

Will the intense rivalry ever stop? I wouldn’t know, but the whole industry may continue to feel the pain of low margins for a long time.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any of the stocks mentioned. The Motley Fool recommends HEXO.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Here’s Why it’s Not Too Late to Buy Cronos Group Stock

The optimism about U.S. federal marijuana legalization and its anticipation are potent bullish triggers for the Canadian cannabis industry.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Canopy Growth Stock Is on a Tear: Is it a Good Buy Now? 

Canopy Growth (TSX:WEED) stock surged by 80% from news out of the U.S., but is enough there without the news…

Read more »